Oslo - Delayed Quote NOK

Photocure ASA (PHO.OL)

51.10
-1.00
(-1.92%)
At close: June 13 at 4:25:28 PM GMT+2
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
532,688
525,388
500,657
393,132
360,540
Cost of Revenue
32,114
30,716
26,137
22,697
24,050
Gross Profit
500,573
494,671
474,521
370,434
336,490
Operating Expense
486,495
474,272
446,714
419,437
342,316
Operating Income
14,078
20,399
27,807
-49,003
-5,826
Net Non Operating Interest Income Expense
-14,265
-15,205
-14,613
-23,667
-21,916
Pretax Income
3,010
8,390
9,740
-71,134
-31,656
Tax Provision
871
11,729
8,761
723
-759
Net Income Common Stockholders
2,138
-3,340
979
-71,857
-30,897
Diluted NI Available to Com Stockholders
2,138
-3,340
979
-71,857
-30,897
Basic EPS
0.08
--
0.04
-2.66
-1.15
Diluted EPS
0.08
--
0.04
-2.66
-1.15
Basic Average Shares
27,035.95
--
27,105.70
27,034.98
26,843.34
Diluted Average Shares
27,036.12
--
27,133.50
27,148.74
27,107.89
Total Operating Income as Reported
42,737
20,399
27,807
-49,003
-5,826
Total Expenses
518,609
504,988
472,851
442,134
366,366
Net Income from Continuing & Discontinued Operation
2,138
-3,340
979
-71,857
-30,897
Normalized Income
2,138
-3,340
2,105.32
-71,265.76
-16,001.70
Interest Income
11,543
12,868
11,714
2,336
1,810
Interest Expense
25,769
28,034
26,327
25,804
23,826
Net Interest Income
-14,265
-15,205
-14,613
-23,667
-21,916
EBIT
28,779
36,424
36,067
-45,330
-7,830
EBITDA
57,853
65,222
63,754
-20,952
16,297
Reconciled Cost of Revenue
32,114
30,716
26,137
22,697
24,050
Reconciled Depreciation
29,074
28,798
27,687
24,378
24,127
Net Income from Continuing Operation Net Minority Interest
2,138
-3,340
979
-71,857
-30,897
Total Unusual Items Excluding Goodwill
0
0
-1,444
-758
-17,220
Total Unusual Items
0
0
-1,444
-758
-17,220
Normalized EBITDA
57,853
65,222
65,198
-20,194
33,517
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-317.68
-166.76
-2,324.70
12/31/2021 - 5/30/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1061.HK ESSEX BIO-TECH
5.090
-4.50%
 
BIOG-B.ST BioGaia AB (publ)
104.20
+0.68%
 
ORX.ST Orexo AB (publ)
19.50
-5.11%
 
SOBI.ST Swedish Orphan Biovitrum AB (publ)
285.00
-2.80%
 
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
16.960
-3.20%
 
HLUN-A.CO H. Lundbeck A/S
31.75
-2.31%
 
DERM Journey Medical Corporation
6.78
-2.73%
 
HLUN-B.CO H. Lundbeck A/S
39.20
-1.66%
 
HCM HUTCHMED (China) Limited
16.90
-4.63%
 
AVDL Avadel Pharmaceuticals plc
9.57
+2.46%